Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

Revolutionary ultrasound tech could be a game changer for the new world of remote patient monitoring, says GlobalData

Following the announcement of MIT’s new study on a newly developed sticker-based tool for continuous ultrasound imaging; James Spencer, Data Scientist at GlobalData, a leading data and analytics company, offers their view: “Ultrasounds are a huge milestone for a mother-to-be. It is a health check-up, but most importantly a first chance to see the child […]
Read more

In vitro diagnostics leads medical device market venture financing reaching $4,305 million so far in 2022 due to COVID-19 and cancer screening testing demand, says GlobalData

The in vitro diagnostics (IVD) market venture financing reached $8,626 million in 2020 and $10,492 million in 2021. In response to the increased demand for IVDs testing for COVID-19, and more options for cancer screenings IVD venture financing has already reached $4,305 million so far in 2022 and is set to lead medical device venture […]
Read more

Shortage of automated external defibrillators and other medical devices a potentially life-threatening issue for patients, says GlobalData

The recent news that automated external defibrillators (AEDs) including wearable and nonwearable versions, chest drains/ suction canisters and autotransfusion systems have been added to the list of medical devices in short supply by the Food and Drug Administration (FDA) on July 20, 2022, is a very real and potentially life-threatening issue for many patients, says GlobalData, […]
Read more

The Neuromodulation Devices market will reach $10.7 billion by 2030, driven by neurological conditions impacting the aging population, says GlobalData

The Neuromodulation Devices market was valued at $6.8 billion globally in 2021, and will reach $10.7 billion in 2030, at a compound annual growth rate (CAGR) of 5.2%. The large prevalence of neurological conditions impacting the aging population is a significant driver of the market, according to GlobalData, a leading data and analytics company.Neuromodulation Devices […]
Read more

FDA approval of deep brain stimulators for treatment-resistant depression will drive APAC market, says GlobalData

Deep brain stimulators (DBS) are traditionally used for the treatment of advanced neurological diseases such as Parkinson’s and Tremors. Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression (TRD). This provides an opportunity for the company to expand the use of these devices and gain […]
Read more

Development of new liquid biopsy test in Australia to allow earlier esophageal cancer detection, says GlobalData

Australia-based Proteomics International Laboratories has recently secured an exclusive worldwide licence to commercialise a liquid biopsy test to detect esophageal cancer. This is expected to increase the diagnosis rates and allow earlier cancer detection in the country, says GlobalData, a leading data and analytics company. GlobalData forecasts Australia’s oncology market to grow at a compound […]
Read more

AMPEL BioSolutions breakthrough treatment method will transform the way healthcare professionals can treat patients, says GlobalData

AMPEL BioSolutions recently announced a breakthrough treatment method that could change how healthcare professionals treat patients who are suffering from autoimmune and infectious diseases, as well as cancer. This technology has the ability to completely transform the way healthcare professionals treat their patients, and in turn, has the potential to improve the quality of life for […]
Read more

India-Australia trade deal to boost access to Cochlear Ltd cochlear implants in India, says GlobalData

The recent Australian-India Economic Cooperation and Trade Agreement (AIECTA) is expected to increase the accessibility and affordability of Cochlear Ltd’s cochlear implants in India owing to gradual removal of tariffs on its hearing implants and accessories, says GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Hearing Implants Market Size (Value, Volume, ASP) by […]
Read more

COVID-19 has accelerated the adoption of telemedicine which is here to stay, says GlobalData

Telemedicine has expanded rapidly since the beginning of the pandemic and is being increasingly adopted in the medical world to treat neurological, respiratory and cardiovascular diseases, says GlobalData, a leading data and analytics company. Telemedicine is the use of electronic communication, such as videoconferencing or phone calls, for the delivery of remote clinical care via […]
Read more

Increased Monkeypox virus surveillance drives new IVD device development, says GlobalData

Heightened disease control protocols left over from the COVID-19 pandemic are paving the way for new Monkeypox in vitro diagnostic (IVD) devices as medical professionals and world leaders are eager to contain the potential monkeypox outbreak, observes GlobalData, the leading data and analytics company. According to the World Health Organization, over 2,000 individuals have been infected […]
Read more

Pulsed field ablation tech gaining popularity in the cardiovascular electrophysiology market, says GlobalData

Due to its improvements in procedure times, its safety over existing techniques and its early clinical success, pulsed field ablation (PFA), a new type of catheter-based ablation, has caught the attention of many electrophysiology device manufacturers, observes GlobalData, a leading data and analytics company. Catheter-based ablation is a procedure routinely carried out in cardiac electrophysiology […]
Read more

Rune Labs’ use of Apple Watch to track Parkinson’s symptoms will be game changing for patients, says GlobalData

Rune Labs receiving clearance from the US Food and Drug Administration (FDA) to use Apple Watch to track symptoms of Parkinson’s disease is exciting news for patients, as doctors can combine data to better personalize treatment for individual patients, says GlobalData, a leading data and analytics company. Rebecca Wu, Medical Analyst at GlobalData, comments: “This is […]
Read more

Domestically produced, high-end medical devices would support India’s aim of becoming a manufacturing hub, says GlobalData

Indian government is making moves towards domestic manufacturing as reliance on foreign imports caused issues during COVID-19 pandemic India was among the top three medical devices markets in Asia-Pacific in 2021 Uttar Pradesh (UP) government’s recently announced manufacturing incentives will help the state become a preferred manufacturing destination in India Shortages of medical supplies during […]
Read more

FDA approval of VisAR will enable medical device companies to capitalize on AR market set to be worth $152 billion by 2030, says GlobalData

Investing in augmented reality (AR) is a wise long-term investment for medical device companies, as the global AR market is estimated to be worth $152 billion by 2030 with enterprise AR making up 65% of total revenue, says GlobalData. The leading data and analytics company points out a recent example of Novarad’s VisAR, a fully […]
Read more

AI set to disrupt women’s healthcare as AI investment to more than double in medical devices industry to $500 million by 2024, says GlobalData

Artificial intelligence (AI) is predicted to disrupt the women’s healthcare market in the US, as medical device companies are forecast to spend $500 million on AI platforms by 2024, up from $200 million in 2019, and representing an impressive compound annual growth rate (CAGR) of 20.6%, according to GlobalData. The leading data and analytics company notes that diagnostic tools such as Ultrasound AI’s Preterm AI (PAI), which will be used to predict preterm birth […]
Read more
1 … 27 28 29 30 31 … 50